Sunder Biomedical Tech Co Stock

Sunder Biomedical Tech Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Sunder Biomedical Tech Co (4115.TWO) as of Aug 21, 2026 is -54.40. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 42.80 — a change of -227.10% (lower).

P/FCF

-54.40

YoY

-227.10%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Sunder Biomedical Tech Co is 2026 -54.40 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Sunder Biomedical Tech Co was 2025 42.80 . It decreases by -227.10% lower compared to the previous year.
Access this data via the Eulerpool API

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Sunder Biomedical Tech Co is -54.40 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Sunder Biomedical Tech Co changed from 42.80 to -54.40, representing a -227.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Sunder Biomedical Tech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co